These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 1336110)

  • 21. The effect of photogenerated site-directed free radicals on surface dihydropyridine binding sites identified with photoaffinity probe (-)-[3H]-azidopine on cultured monkey renal cells.
    Drímal J; Bohácik L
    Methods Find Exp Clin Pharmacol; 1994; 16(6):397-404. PubMed ID: 7530790
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Photoaffinity labeling with dihydropyridine derivatives of crude membranes from rat skeletal, cardiac, ileal, and uterine muscles and whole brain.
    Ichida S; Masada A; Fujisue T; Yoshioka T; Matsuda N
    J Biochem; 1989 May; 105(5):767-74. PubMed ID: 2473981
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel 1,4-dihydropyridine-binding site on mitochondrial membranes from guinea-pig heart, liver and kidney.
    Zernig G; Glossmann H
    Biochem J; 1988 Jul; 253(1):49-58. PubMed ID: 3421952
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Photoaffinity labeling of the purified skeletal muscle calcium antagonist receptor by a novel benzothiazepine, [3H]azidobutyryl diltiazem.
    Naito K; McKenna E; Schwartz A; Vaghy PL
    J Biol Chem; 1989 Dec; 264(35):21211-4. PubMed ID: 2556399
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Photoaffinity labelling of Ca2+ channels with [3H]azidopine.
    Ferry DR; Rombush M; Goll A; Glossmann H
    FEBS Lett; 1984 Apr; 169(1):112-8. PubMed ID: 6325234
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of a phenylalkylamine binding region within the alpha 1 subunit of skeletal muscle Ca2+ channels.
    Striessnig J; Glossmann H; Catterall WA
    Proc Natl Acad Sci U S A; 1990 Dec; 87(23):9108-12. PubMed ID: 2174553
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification and affinity labeling of very high affinity binding sites for the phenylalkylamine series of Ca+ channel blockers in the Drosophila nervous system.
    Pauron D; Qar J; Barhanin J; Fournier D; Cuany A; Pralavorio M; Berge JB; Lazdunski M
    Biochemistry; 1987 Oct; 26(20):6311-5. PubMed ID: 2827725
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stereoselective photoaffinity labelling of the purified 1,4-dihydropyridine receptor of the voltage-dependent calcium channel.
    Striessnig J; Moosburger K; Goll A; Ferry DR; Glossmann H
    Eur J Biochem; 1986 Dec; 161(3):603-9. PubMed ID: 2431906
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The 165-kDa peptide of the purified skeletal muscle dihydropyridine receptor contains the known regulatory sites of the calcium channel.
    Sieber M; Nastainczyk W; Zubor V; Wernet W; Hofmann F
    Eur J Biochem; 1987 Aug; 167(1):117-22. PubMed ID: 2441986
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Subcellular distribution and isolation of the Ca2+ antagonist receptor associated with the voltage regulated Ca2+ channel from rabbit heart muscle.
    Tuana BS; Murphy BJ; Yi Q
    Mol Cell Biochem; 1987 Aug; 76(2):173-84. PubMed ID: 2444872
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Solubilization of the calcium antagonist receptor from rat brain.
    Curtis BM; Catterall WA
    J Biol Chem; 1983 Jun; 258(12):7280-3. PubMed ID: 6305932
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of a novel 1,4-dihydropyridine- and phenylalkylamine-binding polypeptide in calcium channel preparations.
    Vaghy PL; Striessnig J; Miwa K; Knaus HG; Itagaki K; McKenna E; Glossmann H; Schwartz A
    J Biol Chem; 1987 Oct; 262(29):14337-42. PubMed ID: 2443504
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Direct photoaffinity labeling of the high affinity nitrendipine-binding site in subcellular membrane fractions isolated from canine myocardium.
    Campbell KP; Lipshutz GM; Denney GH
    J Biol Chem; 1984 May; 259(9):5384-7. PubMed ID: 6325434
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interaction between calcium channel ligands and calcium channels.
    Glossmann H; Striessnig J; Ferry DR; Goll A; Moosburger K; Schirmer M
    Circ Res; 1987 Oct; 61(4 Pt 2):I30-6. PubMed ID: 2443273
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A rapid procedure for the purification of cardiac 1,4-dihydropyridine receptors from porcine heart.
    Haase H; Striessnig J; Holtzhauer M; Vetter R; Glossmann H
    Eur J Pharmacol; 1991 May; 207(1):51-9. PubMed ID: 1655494
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Purification and affinity labeling of dihydropyridine receptor from rabbit skeletal muscle membranes.
    Kanngiesser U; Nalik P; Pongs O
    Proc Natl Acad Sci U S A; 1988 May; 85(9):2969-73. PubMed ID: 2834724
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 1,4-Dihydropyridine binding sites in moss plasma membranes. Properties of receptors for a calcium channel antagonist.
    Schumaker KS; Gizinski MJ
    J Biol Chem; 1995 Oct; 270(40):23461-7. PubMed ID: 7559508
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endothelin-1 significantly increased number of specific high-affinity 1,4-dihydropyridine (DHP) binding sites photolabelled on vascular smooth muscle cells with (-)-[3H]-azidopine.
    Drímal J; Koprda V
    Physiol Res; 1996; 45(1):51-8. PubMed ID: 8884924
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A unique fluorescent phenylalkylamine probe for L-type Ca2+ channels. Coupling of phenylalkylamine receptors to Ca2+ and dihydropyridine binding sites.
    Knaus HG; Moshammer T; Kang HC; Haugland RP; Glossmann H
    J Biol Chem; 1992 Feb; 267(4):2179-89. PubMed ID: 1310311
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of binding sites for calcium channel antagonists.
    Nakayama H; Kuniyasu A
    Jpn Heart J; 1996 Sep; 37(5):643-50. PubMed ID: 8973377
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.